Loring Wolcott & Coolidge Fiduciary Advisors LLP Covetrus, Inc. Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

  • $11.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
BUY
$25.24 - $30.86 $25,240 - $30,860
1,000 New
1,000 $27,000
Q1 2021

Apr 14, 2021
SELL
$28.29 - $39.89 $28,290 - $39,890
-1,000 Closed
0 $0
Q4 2019

Jan 22, 2020
SELL
$8.8 - $14.93 $70 - $119
-8 Reduced 0.79%
1,000 $13,000
Q3 2019

Nov 05, 2019
SELL
$11.76 - $25.57 $1,787 - $3,886
-152 Reduced 13.1%
1,008 $12,000
Q2 2019

Aug 09, 2019
SELL
$22.88 - $33.27 $915 - $1,330
-40 Reduced 3.33%
1,160 $28,000
Q1 2019

Apr 08, 2019
BUY
$31.52 - $46.19 $37,824 - $55,428
1,200 New
1,200 $38,000

Others Institutions Holding CVET

# of Institutions
8
Shares Held
72.9K
Call Options Held
0
Put Options Held
0
View Full List

About COVETRUS, INC.

CVET Quotes by TradingView
  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Loring Wolcott & Coolidge Fiduciary Advisors LLP Portfolio

Follow Loring Wolcott & Coolidge Fiduciary Advisors LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email